Floating drug delivery systems: An approach to oral controlled drug delivery via gastric retention
作者： B Singh
DOI: 10.1016/S0168-3659(99)00204-7
关键词:
摘要: … It contains 100 mg levodopa and 25 mg benserazide, a peripheral dopa decarboxylase inhibitor. This CR formulation consists of a gelatin capsule that is designed to float on the surface …
elsevier.com
sci-hub.se 参考文章(130)
Jacques Timmermans, [Comparative evaluation of the gastric transit of floating and non-floating matrix dosage forms]. Bulletin et mémoires de l'Académie royale de médecine de Belgique. ,vol. 145, pp. 365- 375 ,(1990)
J. Timmermans, A. J. Moeês, Measuring the resultant-weight of an immersed test material: 1. Validation of an apparatus and a method dedicated to pharmaceutical applications Acta Pharmaceutica Technologica. ,vol. 36, pp. 171- 175 ,(1990)
F.Atyabi., Sharma Hl, Fell Jt, H.A.H. Mohammad, A novel floating system using ion exchange resins In: Proc.int Symp. Control Rel Bioact mater; 1994. p. 809-807.. ,(1994)
V. B. M. Babu, R. K. Khar, In vitro and in vivo studies of sustained-release floating dosage forms containing salbutamol sulfate. Die Pharmazie. ,vol. 45, pp. 268- 270 ,(1990)
Khatib Z, Bogdanov A, Lodianaia Ev, Kharchenko Nv, Palladina Ol, Degtiareva, Opanasiuk Nd, [The use of 3rd-generation antacid preparations for the treatment of patients with nonulcerous dyspepsia and peptic ulcer complicated by reflux esophagitis]. Likars'ka sprava / Ministerstvo okhorony zdorov'ia Ukraïny. pp. 119- ,(1994)
Alastair J. Coupe, Stanley S. Davis, Ian R. Wilding, Variation in Gastrointestinal Transit of Pharmaceutical Dosage Forms in Healthy Subjects Pharmaceutical Research. ,vol. 8, pp. 360- 364 ,(1991) , 10.1023/A:1015849700421
SHOZO MIYAZAKI, HIDEKI YAMAGUCHI, CHIZUKO YOKOUCHI, MASAHIKO TAKADA, WEI-MIN HOU, Sustained-release and intragastric-floating granules of indomethacin using chitosan in rabbits Chemical & Pharmaceutical Bulletin. ,vol. 36, pp. 4033- 4038 ,(1988) , 10.1248/CPB.36.4033
Nagai T, Machida Y, Inouye K, Sannan T, Mechanism based design of inhibitors of neuropeptide degrading enzymes. Drug design and delivery. ,vol. 2, pp. 55- 68 ,(1988)
Hui-Min Hou, Jin-Bing Zhu, Tian-Hua Gu, Ji-Zhen Guo, Shao-Xing Chen, Dai-Jun Song, Pharmacokinetics and pharmacodynamics of diltiazem floating tablets Acta Pharmacologica Sinica. ,vol. 13, pp. 527- 531 ,(1992)
Stanley S. Davis, Anita F. Stockwell, Margaret J. Taylor, John G. Hardy, David R. Whalley, C. G. Wilson, Helle Bechgaard, Finn N. Christensen, The effect of density on the gastric emptying of single- and multiple-unit dosage forms Pharmaceutical Research. ,vol. 3, pp. 208- 213 ,(1986) , 10.1023/A:1016334629169